Skip to Main Content

Paper Details

A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction.
J Med Chem
30
2019
Author NameAffiliation
Hantamalala Ralay RanaivoUniversity of Kentucky
Daniel Martin WattersonNorthwestern University
  • 1 - 2

Datasets

Release 1.2